SynthesisDiabetologia2026

Effectiveness and safety of combining SGLT2 inhibitors and GLP-1 receptor agonists in individuals with type 2 diabetes: a systematic review and meta-analysis of cohort studies.

Julia M T Colombijn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.